HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities

Human immunodeficiency virus type 1 (HIV) infection presently affects more that 40 million people worldwide, and is associated with central nervous system (CNS) disruption in at least 30% of infected individuals. The use of highly active antiretroviral therapy has lessened the incidence, but not the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindl, Kathryn A., Marks, David R., Kolson, Dennis L., Jordan-Sciutto, Kelly L.
Formato: Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914283/
https://www.ncbi.nlm.nih.gov/pubmed/20396973
http://dx.doi.org/10.1007/s11481-010-9205-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914283/
https://www.ncbi.nlm.nih.gov/pubmed/20396973
http://dx.doi.org/10.1007/s11481-010-9205-z

Ejemplares similares